The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates

International Journal of Pharmaceutics

Volumn 435, Issue 2, 2012, Pages 112-114

  Kulo, Aida ^a,b   De Hoon, Jan N ^a   Allegaert, Karel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Developmental pharmacology; Developmental toxicology; Excipients; Maturation; Propylene glycol

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CREATINE; DIGOXIN; EXCIPIENT; GAMMA GLUTAMYLTRANSFERASE; LACTIC ACID; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; PROPYLENE GLYCOL; SODIUM;

CONFERENCE PAPER; DEVELOPMENTAL TOXICITY; DIURESIS; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG EXPOSURE; DRUG FORMULATION; DRUG HALF LIFE; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERANCE; HUMAN; HYPEROSMOLARITY; KIDNEY FUNCTION; LACTIC ACIDOSIS; LIVER FUNCTION; METABOLISM; NEWBORN; NEWBORN INTENSIVE CARE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICOKINETICS; URINARY EXCRETION;

AGE FACTORS; EXCIPIENTS; HUMANS; INFANT, NEWBORN; PROPYLENE GLYCOL;

EID: 84864717784     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.05.014     Document Type: Conference Paper

References (14)

1. K. Allegaert, R. Verbesselt, J.N. van den Anker, M. Rayyan, A. Debeer, G. Naulaers, and J. de Hoon Developmental pharmacology: neonates are not just small adults Acta Clin. Belg. 63 2008 522 530
2. K. Allegaert, S. Vanhaesebrouck, A. Kulo, K. Cosaert, R. Verbesselt, A. Debeer, and J. de Hoon Prospective assessment of short-term propylene glycol tolerance in neonates Arch. Dis. Child. 95 2010 1054 1058
3. K. Allegaert, G.M. Palmer, and B.J. Anderson The pharmacokinetics of intravenous paracetamol in neonates: size matters most Arch. Dis. Child. 96 2011 575 580
4. R.F. De Cock, C.A. Knibbe, A. Kulo, J. de Hoon, R. Verbesselt, M. Danhof, and K. Allegaert Developmental pharmacokinetics of propylene glycol in preterm and term neonates Br. J. Clin. Pharmacol. 27 April 2012 10.1111/j. 1365-2125.2012.04312.x
5. R.F. de Cock, C. Piana, E.H. Krekels, M. Danhof, K. Allegaert, and C.A. Knibbe The role of population PK-PD modelling in paediatric clinical research Eur. J. Clin. Pharmacol. 67 Suppl. 1 2011 5 16
6. C.A.J. Knibbe, and M. Danhof Individualized dosing regimes in children based on population PKPD modelling: are we ready for it? Int. J. Pharm. 415 2011 9 14
7. A. Kulo, K. Allegaert, J. de Hoon, and R. Verbesselt Determination of propylene glycol in human neonates by high performance liquid chromatography with photodiode array detection Chromatographia 73 2011 463 470
8. K. Lau, B.S. Swiney, N. Reeves, K.K. Noguchi, and N.B. Farber Propylene glycol produces excessive apoptosis in the developing mouse brain, alone and in combination with phenobarbital Pediatr. Res. 71 2012 54 62
9. N. Shehab, L.C. Lewis, D.D. Streetman, and S.M. Donn Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates Pediatr. Crit. Care Med. 10 2009 256 259
10. P.A. Speth, T.B. Vree, N.F. Neilen, P.H. de Mulder, D.R. Newell, M.E. Gore, and B.E. de Pauw Propylene glycol pharmacokinetics and effects after intravenous infusion in humans Ther. Drug Monit. 9 1987 255 258
11. A. Whittaker, A.E. Currie, M.A. Turner, D.J. Field, H. Mulla, and H.C. Pandya Toxic additives in medication for preterm infants Arch. Dis. Child. Fetal. Neonatal. Ed. 94 2009 F236 F240
12. K.C. Wilson, C. Reardon, A.C. Theodore, and H.W. Farber Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving iv benzodiazepines: a case series and prospective, observational pilot study Chest 128 2005 1674 1681
13. T. Zar, C. Graeber, and M.A. Perazella Recognition, treatment, and prevention of propylene glycol toxicity Semin. Dial. 20 2007 217 219
14. www.fda.gov/Drugs/DrugsSafety/ucm246002.htm (accessed 01.08.11).